|
| Press Releases |
|
 |
|
| Tuesday, July 23, 2024 |
|
|
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program |
| Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of Avance Clinical's Seoul, Korea office. more info >> |
|
| Tuesday, June 4, 2024 |
|
|
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs. more info >> |
|
| Friday, May 31, 2024 |
|
|
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region. more info >> |
|
| Wednesday, May 8, 2024 |
|
|
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea. more info >> |
|
| Friday, April 19, 2024 |
|
|
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25 |
| Avance Clinical, the award-winning North American and Australian market-leading CRO for biotechs, will attend World Orphan Drug Conference in Boston (April 23-25, 2024) to share their rare diseases drug development expertise with biotechs (booth #730). more info >> |
|
| Thursday, March 28, 2024 |
|
|
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267) more info >> |
|
| Wednesday, February 28, 2024 |
|
|
Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings. (read the full article here) more info >> |
|
| Friday, January 12, 2024 |
|
|
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner |
| Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program. The report found this directly affected clinical programs and budgets. more info >> |
|
| Thursday, October 19, 2023 |
|
|
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US |
| more info >> |
|
| Tuesday, May 30, 2023 |
|
|
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients |
| Avance Clinical, the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early phase biotech companies to speed up the path to regulatory approval, says early phase oncology studies are increasingly more complex and demand more patients. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT/SGT
|
|
|
Denmark Buys Four MQ-9B SkyGuardians From GA-ASI
Jul 23, 2025 22:00 HKT/SGT
|
|
|
China's Largest Agricultural Internet Company Yimutian Set to List on Nasdaq
Jul 23, 2025 20:03 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Fifth Year as Official Apparel Partner for 2025 British Open Polo Championship for the Cowdray Gold Cup, Broadcast by the Sports Brand Globally on ESPN for the First Time
Jul 23, 2025 19:00 HKT/SGT
|
|
|
Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization's certification test
Jul 23, 2025 13:10 JST
|
|
|
Sharp Exhibits at the 2nd SPEXA - International Space Business Expo
Jul 23, 2025 10:30 JST
|
|
|
Launch of Beova(R) Tablets in Thailand for Overactive Bladder
Jul 23, 2025 10:07 JST
|
|
|
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
Jul 23, 2025 10:00 JST
|
|
|
Peapack-Gladstone Financial Corp (NASDAQ: PGC) Second Quarter 2025 Financial Results
Jul 22, 2025 19:44 HKT/SGT
|
|
|
Military Metals Announces Grab Sample Results up to 40.6% Antimony and 106.5 gpt Gold from Stockpile of Historically Mined Material at West Gore Antimony-Gold Project, Nova Scotia
Jul 22, 2025 19:39 HKT/SGT
|
|
|
35th Hong Kong Book Fair attracts some 900,000 visits despite typhoon
Jul 22, 2025 19:22 HKT/SGT
|
|
|
Satellite Direct-to-Device: CaoCao Becomes the World's First to Embed LEO Satellite Communication Services in the Robotaxi Platform
Jul 22, 2025 18:53 HKT/SGT
|
|
|
InfoComm India 2025 Visitor Registration Opens Strong Amidst Surging Demand for AI and Immersive AV
Jul 22, 2025 18:44 HKT/SGT
|
|
|
Mitsubishi Motors to Terminate Its Joint Venture Partnership with Shenyang Aerospace Mitsubishi Motors Engine Manufacturing
Jul 22, 2025 17:00 JST
|
|
|
Capital Markets Malaysia Expands Simplified ESG Disclosure Guide with a GHG Emission Calculator for SMEs
Jul 22, 2025 14:15 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
